The UV infection control device is a disinfecting system that use UV rays to kill microorganism present in the various healthcare settings such as hospitals, clinics, ambulatory surgical centers, research center, emergency departments, and others. Healthcare-associated infections are on the rise every year. These are caused by microorganisms, which include fungi, viruses, bacteria, and parasites that can seriously affect the patients. The devices emit UV light that reflects off walls and other surfaces and is absorbed by bacteria. The light-sensitive porphyrin molecules of bacteria are excited, leading to oxidative damage and cell death.
Factors that drive the growth of the UV infection control device market include an increase in government focus on infection control programs. For instance, the American Hospital Association published a study in 2015 in which it estimated more than 50% of U.S. hospitals had means of infection control. Additionally, the rising adoption of technologically advanced UV equipment further supplements the growth of the market. However, the high cost of UV infection control devices and strict regulations hinder the growth of the market globally. However, high growth prospects in developing markets can provide novel opportunities for the UV infection control device market growth.
Request a Sample@ https://www.qyresearchmedical.com/sample/119478
By type, the market is classified into mobile, stationary, and other types of UV infection control devices. The mobile segment dominated the market in terms of revenue in 2019 and is expected to continue to maintain the lead over the forecast period. This is attributed to its mobility as the device is light and can be moved to different settings. In addition, the cost of mobile UV infection control devices is lower than the stationary IV infection control devices. Various benefits offered by these devices can also be attributed to the growth of the market. For instance, these devices control infectious diseases by killing them instead of inhibiting the growth of infectious diseases. Furthermore, these mobile units are specifically designed for the ease of use and elimination of human error.
On the basis of end user, the market is divided into hospitals, clinics, and others. The hospital segment captured the largest share of the UV infection control device market in 2019 due to factors such as a rise in usage of these devices that are used in the medical establishments due to a surge in cases of hospital-acquired infections. In addition, the surge in the number of hospitals worldwide is further supporting the market growth. The hospital segment is the fastest-growing end user segment in the market.
Region-wise, the market is segmented into North America, Europe, Asia Pacific, and Latin America, and Middle East & Africa. North America accounted for the major UV infection control devices market share in 2019 and is expected to continue this trend, owing to the presence of well-established healthcare infrastructure, higher buying power, & high adoption of advanced medical devices. Additionally, a rise in cases of hospital-acquired infection is another major factor that boosts the growth of the market.
On the other side, Asia Pacific is estimated to register the fastest growth during the forecast period, which is attributed to highly populated countries, with China being the first and India the second most populated country. Therefore, the region has the potential to offer a huge patient base, which is expected to boost the growth of the Asia-Pacific UV infection control devices market. Moreover, the improvements in health standards, a surge in disposable incomes, and advancements in technology for the development of new UV infection control devices also contribute to the growth of the market in the region.
The UV infection control device market is quite competitive, and the leading players in the market have adopted various strategies to capture maximum market share. These include collaboration, product launch, partnership, and acquisition. Some of the players in the UV infection control device market are DocMorris, CVS Health Corporation, Express Scripts Holding Company, Giant Eagle Inc., Optum Rx Inc., Rowlands Pharmacy, The Kroger Co., Walgreen Co., Walmart Stores Inc., and Apollo Pharmacy.
Segments Covered in the Report
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2023 to 2032. For the purpose of this study,has segmented the global infection control device market report on the basis of type, end user, and region:
By Type (Revenue, USD Million, 2023 – 2032)
By End User (Revenue, USD Million, 2023 – 2032)
By Region (Revenue, USD Million, 2023 – 2032)
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119478/1500
You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us:
URL – http://www.qyresearchmedical.com/